Visão geral da empresa Broncus
Fabricação de produtos farmacêuticosIndústria
Bucking bronchial conditions is what Broncus Technologies is all about. The company develops medical devices known as bronchoscopic interventions that treat chronic lung diseases. Its commercial LungPoint bronchoscopic system and Yield biopsy tools are used in the diagnosis and treatment of lung cancer and other diseases. Its Exhale treatment system, which is in clinical trial stages for the treatment of emphysema, includes the Exhale drug-eluting stent and related implements used in the company's patented Airway Bypass procedure for collapsed airways. Other disease targets include pulmonary hypertension and chronic bronchitis. Broncus Technologies is backed by venture capital firms.